Evidence map›Paper›PMID 22210044›Full record

ArticleCancer genomics & proteomics2012

Comparative proteomic analysis of a cytosolic fraction from β3 integrin-deficient cells.

Jason A Bush, Hideki Kitaura, Yuliang Ma, Steven L Teitelbaum, F Patrick Ross, Jeffrey W Smith

Abstract read
In one paragraph

Article in Cancer genomics & proteomics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 84% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Jason A BushBiology Department,College of Science and Mathematics, California State University-Fresno, 2555 E. Ramon Ave., M/S SB73, Fresno, CA 93740, USA. jbush@csufresno.edu
Hideki Kitaura
Yuliang Ma
Steven L Teitelbaum
F Patrick Ross
Jeffrey W Smith
California State University, Fresno · US

Funding

Tumor Microenvironment and Cancer ImmunologyP30CA030199 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI Michael Jackson · 1985 to 2026
$107.2M
CORE 6 : PROJECT LEADERSHIP AND ADMINISTRATIONU54RR020843 · NCRR · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI SMITH, JEFFREY W · 2004 to 2009
$19.1M
Mechanisms of RANKL Mediated Osteoclast ActivationR01AR032788 · NIAMS · WASHINGTON UNIVERSITY · PI TEITELBAUM, STEVEN L · 1987 to 2012
$6.6M
MECHANISMS OF AVB3 INTEGRIN MEDIATED BONE RESORPTIONR01AR046523 · NIAMS · WASHINGTON UNIVERSITY · PI TEITELBAUM, STEVEN L · 2000 to 2009
$4.0M
Mechanisms of AVB3 Integrin Mediated Bone ResorptionR37AR046523 · NIAMS · WASHINGTON UNIVERSITY · PI TEITELBAUM, STEVEN L · 2010 to 2019
$3.3M
M-CSF SIGNALING IN OSTEOCLAST FORMATION AND FUNCTIONR01AR046852 · NIAMS · WASHINGTON UNIVERSITY · PI ROSS, F. PATRICK · 2000 to 2008
$2.2M
RANK Ligand is a Bone Anabolic AgentR01AR048853 · NIAMS · WASHINGTON UNIVERSITY · PI TEITELBAUM, STEVEN L · 2002 to 2006
$1.8M
Bone Loss and Its Prevention in HIV PatientsR01AR048812 · NIAMS · WASHINGTON UNIVERSITY · PI ROSS, F. PATRICK · 2002 to 2006
$1.7M
CIHR 10FB-0115NCI NIH HHS CA30199NCI NIH HHS P30 CA030199NCRR NIH HHS 5U54RR020843-02NCRR NIH HHS U54 RR020843NIAMS NIH HHS AR032788NIAMS NIH HHS AR046523NIAMS NIH HHS AR046852NIAMS NIH HHS AR048812NIAMS NIH HHS AR048853NIAMS NIH HHS R01 AR032788NIAMS NIH HHS R01 AR046523NIAMS NIH HHS R01 AR046852NIAMS NIH HHS R01 AR048812NIAMS NIH HHS R01 AR048853NIAMS NIH HHS R37 AR046523
6 · The paper itself

Abstract

Integrins are heterodimeric transmembrane receptors involved in sensing and transmitting informational cues from the extracellular environment to the cell. This study explored sub-proteome changes in response to elimination of the β3 integrin using a knockout murine model. Cleavable isotope-coded affinity tagging (cICAT) in combination with sub-cellular fractionation, multiple dimensions of separation and tandem mass spectrometry (MS/MS) were used to characterize differentially expressed proteins among β3 integrin(-/-) (β3(-/-)) mouse embryonic fibroblasts and isogenic wild-type (WT) controls. From a cytosolic protein fraction, 48 proteins were identified, in which expression differed by > 1.5-fold. Predominant ontological groups included actin-binding/cytoskeletal proteins and protease/protease inhibitors. Interestingly, β3 integrin expression was inversely correlated with expression of cathepsin B, a lysosomal cysteine protease, as its expression was greater by over 3.5-fold in the β3(-/-) cells. This inverse correlation was also observed in stable heterologous cells transfected with β3 integrin, where the intracellular expression and activity of cathepsin B was lower compared to control cells. Our data suggests that the composition of the cellular proteome is influenced by integrin expression patterns and reveals a strong functional relationship between β3 integrin and cathepsin B.

Indexed as

ProteomicsAnimalsCathepsin BCytosolFibroblastsHEK293 CellsHumansIntegrin beta3Isotope LabelingMiceMice, 129 StrainMice, Inbred C57BLMice, KnockoutPaxillinProtein BindingProteomeCathepsin BIntegrin beta3PaxillinProteome

Identifiers

PMID22210044
PMCPMC3627548
OpenAlexW2109399210

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.